(Q34065515)

30 July 2017

title

Tuberculosis control policies in major metropolitan health departments in the United States. VI. Standard of practice in 1996. (English)

1 reference

30 July 2017

main subject

United States of America

0 references

1 reference

Leff DR

1

1 reference

30 July 2017

Leff AR

series ordinal

2

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 November 1997

1 reference

American Journal of Respiratory and Critical Care Medicine

30 July 2017

published in

1 reference

30 July 2017

volume

156

1 reference

30 July 2017

issue

5

1 reference

30 July 2017

page(s)

1487-1494

1 reference

Tuberculosis control policies in major metropolitan health departments in the United States. IV. Standards in 1988.

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.5.9704105

Tuberculosis control policies in major metropolitan health departments in the United States. V. Standard of practice in 1992.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.5.9704105

Treatment of tuberculosis in patients with advanced human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.5.9704105

Resurgent tuberculosis in New York City. Human immunodeficiency virus, homelessness, and the decline of tuberculosis control programs

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.5.9704105

Incidence and natural history of Mycobacterium avium-complex infections in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.5.9704105

Isoniazid Preventive Therapy for Tuberculosis: Decision Analysis Considering Ethnicity and Gender

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.5.9704105

An outbreak of tuberculosis in a shelter for homeless men. A description of its evolution and control

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.5.9704105

Validity of a decision tree for predicting active pulmonary tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.5.9704105

USPHS Tuberculosis Short-Course Chemotherapy Trial 21: effectiveness, toxicity, and acceptability. The report of final results

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.5.9704105

A 62-dose, 6-month therapy for pulmonary and extrapulmonary tuberculosis. A twice-weekly, directly observed, and cost-effective regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.5.9704105

Increased mortality and tuberculosis treatment failure rate among human immunodeficiency virus (HIV) seropositive compared with HIV seronegative patients with pulmonary tuberculosis treated with "standard" chemotherapy in Kinshasa, Zaire

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.5.9704105

10.1164/AJRCCM.156.5.9704105

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference